These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7876631)

  • 21. Role of Nramp1 deletion in Chlamydia infection in mice.
    Pal S; Peterson EM; de La Maza LM
    Infect Immun; 2000 Aug; 68(8):4831-3. PubMed ID: 10899900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection.
    Murdin AD; Dunn P; Sodoyer R; Wang J; Caterini J; Brunham RC; Aujame L; Oomen R
    J Infect Dis; 2000 Jun; 181 Suppl 3():S544-51. PubMed ID: 10839756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distribution and effect of Chlamydia trachomatis in CBA mice inoculated genitally, intra-articularly or intravenously.
    Tuffrey M; Falder P; Thomas B; Taylor-Robinson D
    Med Microbiol Immunol; 1984; 173(1):29-35. PubMed ID: 6472198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neutralization of interleukin-17 aggravates respiratory infection induced by Chlamydia trachomatis in mice].
    Zhang XY; Li Q; Zhang YQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):613-8. PubMed ID: 23939174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models for Chlamydia pneumoniae infection.
    Laitinen K; Alakärppä H; Laurila A; Leinonen M
    Scand J Infect Dis Suppl; 1997; 104():15-7. PubMed ID: 9259074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse models of C. pneumoniae infection and atherosclerosis.
    Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C
    J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
    Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S505-7. PubMed ID: 10839748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone.
    Malinverni R; Kuo CC; Campbell LA; Grayston JT
    J Infect Dis; 1995 Aug; 172(2):593-4. PubMed ID: 7622914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J mice.
    Törmäkangas L; Saario E; Bem David D; Bryskier A; Leinonen M; Saikku P
    J Antimicrob Chemother; 2004 Jun; 53(6):1101-4. PubMed ID: 15117927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathology of human chlamydia infections].
    Theegarten D
    Pneumologie; 2004 Apr; 58(4):280-2. PubMed ID: 15098146
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model.
    Törmäkangas L; Vuorela P; Saario E; Leinonen M; Saikku P; Vuorela H
    Biochem Pharmacol; 2005 Oct; 70(8):1222-30. PubMed ID: 16139801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of Arterial Infection by Chlamydia pneumoniae.
    Shor A
    Circulation; 2001 Sep; 104(13):E75. PubMed ID: 11571261
    [No Abstract]   [Full Text] [Related]  

  • 33. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis.
    Yang ZP; Kuo CC; Grayston JT
    Infect Immun; 1993 May; 61(5):2037-40. PubMed ID: 8478091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to cigarette smoke and Chlamydia pneumoniae infection in mice: Effect on infectious burden, systemic dissemination and cytokine responses: A pilot study.
    Kumar S; Smith-Norowitz TA; Kohlhoff S; Apfalter P; Roblin P; Kutlin A; Harkema J; Ng SP; Doherty-Lyons S; Zelikoff JT; Hammerschlag MR
    J Immunotoxicol; 2016; 13(1):77-83. PubMed ID: 25640695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.
    Törmäkangas L; Alakärppä H; David DB; Leinonen M; Saikku P
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3655-61. PubMed ID: 15388416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model.
    Erkkilä L; Saario E; Laitinen K; Saikku P; Leinonen M
    Vaccine; 2008 May; 26(20):2503-9. PubMed ID: 18433949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment.
    Laitinen K; Laurila AL; Leinonen M; Saikku P
    Infect Immun; 1996 Apr; 64(4):1488-90. PubMed ID: 8606126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
    Penttilä T; Wahlström E; Vuola JM; Sarvas M; Puolakkainen M
    Comp Med; 2006 Aug; 56(4):272-8. PubMed ID: 16941954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mouse model of Chlamydia trachomatis pneumonitis.
    Kuo C; Chen WJ
    J Infect Dis; 1980 Feb; 141(2):198-202. PubMed ID: 7365276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.